Novavax Inc. Stock Slides 5.6%, Underperforms Peers
Dow Jones2026/09/10 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. slipped 5.6% to $9.30 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.7% to 26,081.72 and Dow Jones Industrial Average falling 0.6% to 52,064.10.
This was the stock's fourth consecutive day of losses.
Novavax Inc. closed 22.3% below its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.3% to $266.35, Pfizer Inc. fell 0.5% to $27.65, and Merck & Co. Inc. fell 1.91% to $144.71.
Trading volume totaled 5.8 million, compared to the 50-day average of 4.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 10, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "new Bond King" Gundlach warns: The next recession may trigger a US debt crisis, and US Treasury bonds will no longer be a safe haven.
The "new bond king" Jeffrey Gundlach has warned that the next round of economic downturn in the United States could trigger a debt crisis, pushing long-term U.S. Treasury yields sharply higher. This would break the decades-old conventional belief that bonds are always a safe haven during economic turbulence.
Nvidia (NVDA.US) further strengthens AI infrastructure by investing $2 billion in Brookfield (BAM.US) Global AI Fund, which aims to raise $10 billion.
Nvidia has invested $2 billion in the Global Artificial Intelligence Infrastructure Fund under Brookfield Asset Management.
LCNB Chief Wealth Officer Michael Miller to Retire
Loop Industries to Evaluate Alternatives, India Joint Venture Financing